ReviewHypertension research : official journal of the Japanese Society of Hypertension2026
Magnesium and blood pressure regulation: systemic and renal mechanisms.
Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Experimental and clinical evidence have demonstrated that Mg deficiency contributes to elevated blood pressure (BP), whereas Mg supplementation exerts modest but consistent antihypertensive effects. The systemic effects of Mg supplementation and/or deficiency on BP have been investigated in relation to vascular smooth muscle cells (VSMCs), the renin-angiotensin-aldosterone system (RAAS), endothelial function, the sympathetic nervous system, and inflammation associated with oxidative stress. Some of these mechanisms are supported by compelling evidence, whereas others remain controversial. In the kidney, following glomerular filtration, ~95% of filtered Mg is reabsorbed along the renal tubules. In the proximal tubule (PT), Mg reabsorption occurs mainly via a paracellular transport pathway driven by a negative transepithelial electrical gradient. In contrast, in the thick ascending limb of Henle's loop (TAL), Mg reabsorption is regulated by electrochemical gradients generated through the coordinated activity of transporters such as the Na-K-2Cl cotransporter (NKCC2) and Na-K-ATPase. In the distal convoluted tubule (DCT), transient receptor potential melastatin 6 and 7 (TRPM6/7) channels tightly regulate the transcellular Mg reabsorption pathway. Hypertension is associated with increased urinary Mg excretion, resulting in relative Mg deficiency. Accumulating evidence suggests that Mg deficiency contributes to the pathogenesis of salt-sensitive and/or implementation hypertension, presumably through mechanisms involving Mg, Na and K transporters, mainly in the TAL and DCT.In this review, we discuss both systemic and renal mechanisms linking Mg to BP regulation. A better understanding of the interactions among Mg, Na, and K transport may provide novel insights into the role of Mg in hypertension. Mg exerts both BP raising and lowering effects depending on the body Mg status. Mg deficiency is associated with increase in BP through the multifaceted systemic and renal mechanisms. Experimental studies have shown that Mg deficiency-induced hypertension can be salt-sensitive and may be associated with implementation hypertension. The pressure-natriuresis curve shifts rightward and downward as salt sensitivity develops, requiring a higher BP to achieve the same level of sodium excretion.
Indexed as
Identifiers
42552400What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.